Anti-inflammaging effects of Lactobacillus brevis OW38 in aged mice

Beneficial Microbes

Volumn 7, Issue 5, 2016, Pages 707-718

  Jeong, J J ^a   Kim, K A ^a   Hwang, Y J ^a   Han, M J ^a   Kim, D H ^a  

^a Kyung Hee University   (South Korea)

Author keywords

Colitis; Gut microbiota; Inflammaging; Lactobacillus brevis; Lipopolysaccharide; Memory

Indexed keywords

CLAUDIN 1; DOUBLECORTIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; MYELOPEROXIDASE; OCCLUDIN; PROBIOTIC AGENT; PROTEIN P16; PROTEIN P53; PROTEIN ZO1; RNA 16S; TUMOR NECROSIS FACTOR; ANTIINFLAMMATORY AGENT; BIOLOGICAL MARKER; BRAIN DERIVED NEUROTROPHIC FACTOR;

AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BACTEROIDETES; BLOOD LEVEL; BODY FLUID; COLITIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; FIRMICUTES; GENE ACTIVATION; HIPPOCAMPUS; KIMCHI; LACTIC ACID BACTERIUM; LACTOBACILLUS BREVIS; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEOBACTERIA; RNA SEQUENCE; SENESCENCE; TREATMENT DURATION; TREATMENT OUTCOME; ANIMAL; BRAIN; COLON; HUMAN; IMMUNOLOGY; INTESTINE FLORA; MEMORY DISORDER; METABOLISM; ORAL DRUG ADMINISTRATION; PERITONEUM MACROPHAGE;

ADMINISTRATION, ORAL; ANIMALS; ANTI-INFLAMMATORY AGENTS; BIOMARKERS; BRAIN; BRAIN-DERIVED NEUROTROPHIC FACTOR; COLITIS; COLON; GASTROINTESTINAL MICROBIOME; HUMANS; LACTOBACILLUS BREVIS; LIPOPOLYSACCHARIDES; MACROPHAGES, PERITONEAL; MALE; MEMORY DISORDERS; MICE; NF-KAPPA B; PROBIOTICS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 85006733623     PISSN: 18762883     EISSN: 18762891     Source Type: Journal    
DOI: 10.3920/BM2016.0016     Document Type: Article

References (41)

1. Alonso-Fernández, P. and De la Fuente, M., 2011. Role of the immune system in aging and longevity. Current Aging Science 4: 78-100.
2. Araujo, J.A., Studzinski, C.M., Head, E., Cotman, C.W. and Milgram, N.W., 2005. Assessment of nutritional interventions for modification of age-associated cognitive decline using a canine model of human aging. Age 27: 27-37.
3. Cammarota, G., Ianiro, G., Bibbò, S. and Gasbarrini, A., 2014. Gut microbiota modulation: probiotics, antibiotics or fecal microbiota transplantation? Internal and Emergency Medicine 4: 365-373.
4. Chapple, I.L., 1997. Reactive oxygen species and antioxidants in inflammatory diseases. Journal of Clinical Periodontology 24: 287-296.
5. Collins, M.D. and Gibson, G.R., 1999. Probiotics, prebiotics, and synbiotics: approaches for modulating the microbial ecology of the gut. American Journal of Clinical Nutrition 69: 1052s-1057s.
6. Cornelius, C., Koverech, G., Crupi, R., Di Paola, R., Koverech, A., Lodato, F., Scuto, M., Salinaro, A.T., Cuzzocrea, S., Calabrese, E.J. and Calabrese, V., 2014. Osteoporosis and Alzheimer pathology: role of cellular stress response and hormetic redox signaling in aging and bone remodeling. Frontiers in Pharmacology 5: 120.
7. De Baera, S., Eeckhaut, B., Steppe, M., De Maesschalck, C., De Backer, P., Van Immerseel, F. and Croubels, S., 2013. Development of a HPLC-UV method for the quantitative determination of four shortchain fatty acid and lactic acid produced by intestinal bacteria during in vitro fermentation. Journal of Pharmaceutical and Biomedical Analysis 80: 107-115.
8. De Roock, S., Van Elk, M., Hoekstra, M.O., Prakken, B.J., Rijkers, G.T. and De Kleer, I.M., 2011. Gut derived lactic acid bacteria induce strain specific CD4(+) T cell responses in human PBMC. Clinical Nutrition 30: 845-851.
9. Doody, R.S., 1999. Therapeutic standards in Alzheimer disease. Alzheimer Disease and Associated Disorders 13, Suppl. 2: S20-26.
10. Federico, A., Morgillo, F., Tuccillo, C., Ciardiello, F. and Loguercio, 2007. Chronic inflammation and oxidative stress in human carcinogenesis. International Journal of Cancer 121: 2381-2386.
11. Ghosh, S., Lertwattanarak, R., Garduño, J.D., Galeana, J.J., Li, J., Zamarripa, F., Lancaster, J.L., Mohan, S., Hussey, S. and Musi, N., 2015. Elevated muscle TLR4 expression and metabolic endotoxemia in human aging. Journal of Gerontology, series A, Biological Sciences and Medical Science 70: 232-246.
12. Gkouskou, K.K., Deligianni, C., Tsatsanis, C. and Eliopoulos, A.G., 2014. The gut microbiota in mouse models of inflammatory bowel disease. Frontiers in Cellular and Infection Microbiology 4: 28.
13. Hopkins, M.J., Sharp, R. and Macfarlane, G.T., 2001. Age and disease related changes in intestinal bacterial populations assessed by cell culture, 16S rRNA abundance, and community cellular fatty acid profiles. Gut 48: 198-205.
14. Jang, S.E., Hyam, S.R., Han, M.J., Kim, S.Y., Lee, B.G. and Kim, D.H., 2013. Lactobacillus brevis G-101 ameliorates colitis in mice by inhibiting NF-κB, MAPK and AKT pathways and by polarizing M1 macrophages to M2-like macrophages. Journal of Applied Microbiology 115: 888-896.
15. Jeong, J.J., Kim, K.A., Jang, S.E., Woo, J.Y., Han, M.J. and Kim, D.H., 2015a. Orally administrated Lactobacillus pentosus var. plantarum C29 ameliorates age-dependent colitis by inhibiting the nuclear factor-kappa B signaling pathway via the regulation of lipopolysaccharide production by gut microbiota. PLoS One 10: e0116533.
16. Jeong, J.J., Woo, J.Y., Ahn, Y.T., Shim, J.H., Huh, C.S., Im, S.H., Han, M.J. and Kim, D.H., 2015b. The probiotic mixture IRT5 ameliorates age-dependent colitis in rats. International Immunopharmacology 26: 416-422.
17. Jeong, J.J., Woo, J.Y., Kim, K.A., Han, M.J. and Kim, D.H., 2015c. Lactobacillus pentosus var. plantarum C29 ameliorates agedependent memory impairment in Fischer 344 rats. Letters in Applied Microbiology 60: 307-314.
18. Jung, I.H., Jung, M.A., Kim, E.J., Han, M.J. and Kim, D.H., 2012. Lactobacillus pentosus var. plantarum C29 protects scopolamineinduced memory deficit in mice. Journal of Applied Microbiology 113: 1498-1506.
19. Kauppinen, A, Suuronen, T., Ojala, J., Kaarniranta, K. and Salminen, A., 2013. Antagonistic crosstalk between NF-κB and SIRT1 in the regulation of inflammation and metabolic disorders. Cellular Signalling 25: 1939-1948.
20. Kim, K.A., Gu, W., Lee, I.A., Joh, E.H. and Kim, D.H., 2012. High fat diet-induced gut microbiota exacerbates inflammation and obesity in mice via the TLR4 signaling pathway. PLoS One 7: e47713.
21. Kim, K.A., Jeong, J.J., Yoo, S.Y. and Kim, D.H., 2016. Gut microbiota lipopolysaccharide accelerates inflamm-aging in mice. BMC Microbiology 16: 9.
22. Liochev, S.I., 2013. Reactive oxygen species and the free radical theory of aging. Free Radical Biology and Medicine 60: 1-4.
23. Maes, M. and Leunis, J.C., 2008. Normalization of leaky gut in chronic fatigue syndrome (CFS) is accompanied by a clinical improvement: effects of age, duration of illness and the translocation of LPS from gram-negative bacteria. Neuroendocrinology Letters 29: 902-910.
24. Maes, M., Twisk, F.N., Kubera, M., Ringel, K., Leunis, J.C. and Geffard, M., 2012. Increased IgA responses to the LPS of commensal bacteria is associated with inflammation and activation of cell-mediated immunity in chronic fatigue syndrome. Journal of Affective Disorders 136: 909-917.
25. Man, A.L., Bertelli, E., Rentini, S., Reqoli, M., Briars, G., Marini, M., Watson, A.J. and Nicoletti, C., 2015. Age-associated modifications of intestinal permeability and innate immunity in human small intestine. Clinical Science 129: 515-527.
26. Mitsuoka, T., 1990. Bifidobacteria and their role in human health. Journal of Industrial Microbiology and Biotechnology 6: 263-267.
27. Nakanishi, H., Hayashi, Y. and Wu, Z., 2011. The role of microglial mtDNA damage in age-dependent prolonged LPS-induced sickness behavior. Neuron Glia Biology 7: 17-23.
28. Park, E.J., Thomson, A.B. and Clandinin, M.T., 2010. Protection of intestinal occludin tight junction protein by dietary gangliosides in lipopolysaccharide-induced acute inflammation. Journal of Pediatric Gastroenterology and Nutrition 50: 321-328.
29. Park, S.H., Kim, K.A., Ahn, Y.T., Jeong, J.J., Huh, C.S. and Kim, D.H., 2015. Comparative analysis of gut microbiota in elderly people of urbanized towns and longevity villages. BMC Microbiology 15: 49.
30. Rafii, F., Ruseler-Van Embden, J.G. and Van Lieshout, L.M., 1999. Changes in bacterial enzymes and PCR profiles of fecal bacteria from a patient with ulcerative colitis before and after antimicrobial treatments. Digestive Diseases and Sciences 44: 637-642.
31. Rajilic-Stojanovic, M., Heilig, H.G., Molenaar, D., Kajander, K., Surakka, A., Smidt, H. and De Vos, W.M., 2009. Development and application of the human intestinal tract chip, a phylogenetic microarray: analysis of universally conserved phylotypes in the abundant microbiota of young and elderly adults. Environmental Microbiology 11: 1736-1751.
32. Salminen, S., Von Wright, A., Morelli, L., Marteau, P., Brassart, D., De Vos, W.M., Fondén, R., Saxelin, M., Collins, K., Mogensen, G., Birkeland, S.E. and Mattila-Sandholm, T., 1998. Demonstration of safety of probiotics-a review. International Journal of Food Microbiology 44: 93-106.
33. Singh, T. and Newman, A.B., 2011. Inflammatory markers (TNF-α, c-reactive protein, IL-6), in population studies of aging. Ageing Research Reviews 10: 319-329.
34. Smith, P.D., Smythies, L.E., Shen, R., Greenwell-Wild, T., Gliozzi, M. and Wahl, S.M., 2011. Intestinal macrophages and response to microbial encroachment. Mucosal Immunology 4: 31-42.
35. Sohal, R.S. and Allen, R.G., 1990. Oxidative stress as a causal factor in differentiation and aging: a unifying hypothesis. Experimental Gerontology 25:499-522.
36. Tabuchi, M., Ozaki, M., Tamura, A., Yamada, N., Ishida, T., Hosoda, M. and Hosono, A., 2003. Antidiabetic effect of Lactobacillus GG in streptozotocin-induced diabetic rats. Bioscience, Biotechnology, and Biochemistry 67: 1421-1424.
37. Taleban, S., Colombel, J.F., Mohler, M.J. and Fain, M.J., 2015. Inflammatory bowel disease and the elderly: a review. Journal of Crohn's and Colitis 9: 507-515.
38. Tariot, P.N., Patel, S.V., Cox, C. and Henderson, R.E., 1996. Agerelated decline in central cholinergic function demonstrated with scopolamine. Psychopharmacology 125: 50-56.
39. Viña, J., Borras, C., Abdelaziz, K.M., Garcia-Valles, R. and Gomez-Cabrera, M.C., 2013. The free radical theory of aging revisited: the cell signaling disruption theory of aging. Antioxidants and Redox Signaling 19: 779-787.
40. Yu, B.P. and Yang, R., 1996. Critical evaluation of the free radical theory of aging. Annals of the New York Academy of Sciences 786: 1-11.
41. Zukiewicz-Sobczak, W., Wróblewska, P., Adamczuk, P. and Silny, W., 2014. Probiotic lactic acid bacteria and their potential in the prevention and treatment of allergic diseases. Cent. European Journal of Immunology 39: 104-108.